PANKAJ KHANDELWAL, MD
Medical Oncology Physician · ODESSA, TX
Individual Active NPI 1114964756
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 484 | 171,309 | $14,825,292 | $4,345,593 | $3,464,610 |
| 2023 | 485 | 167,522 | $11,342,310 | $2,856,228 | $2,272,958 |
| 2022 | 469 | 145,737 | $10,959,266 | $3,062,919 | $2,445,359 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1756 | Injection, iron sucrose, 1 mg | 19,200 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13,525 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,000 | $55 | $44 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,350 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,913 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,446 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 5,540 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 2,520 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,096 | $0 | $0 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1,710 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,320 | $1 | $1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 1,120 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | J3514 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1083656078
- NPI 1346331063
- NPI 1497319636
- NPI 1346323888
- NPI 1447414776
- NPI 1063676245
- NPI 1730463324
- NPI 1518066521
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.